Veeva SystemsMEX:VEEV -0.79%93 Return-on-Tangible-Equity is 15.53% as of Apr. 2026, which is 19% below its 10-year median of 19.28. GuruFocus rates MEX:VEEV with a GF Score™ of 93/100 and a GF Value™ of MXN5,077.50 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 580 Healthcare Providers & Services companies, Veeva Systems ranks better than 60.52% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Veeva Systems's annualized net income for the quarter that ended in Apr. 2026 was MXN18,282 Mil. Veeva Systems's average shareholder tangible equity for the quarter that ended in Apr. 2026 was MXN117,717 Mil. Therefore, Veeva Systems's annualized Return-on-Tangible-Equity for the quarter that ended in Apr. 2026 was 15.53%.
The historical rank and industry rank for Veeva Systems's Return-on-Tangible-Equity or its related term are showing as below:
MEX:VEEV'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 14.33 Med: 19.28 Max: 27.25
Current: 14.73
During the past 13 years, Veeva Systems's highest Return-on-Tangible-Equity was 27.25%. The lowest was 14.33%. And the median was 19.28%.
MEX:VEEV's Return-on-Tangible-Equity is ranked better than 60.52% of 580
companies
in the Healthcare Providers & Services industry
Industry Median: 10.065
vs MEX:VEEV: 14.73
Veeva Systems (MEX:VEEV) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Veeva Systems Return-on-Tangible-Equity Related Terms
Veeva Systems Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Veeva Systems's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:VEEV vs BTSG, TEM, HQY: Return-on-Tangible-Equity Comparison
For the Health Information Services subindustry, Veeva Systems's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veeva Systems Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Veeva Systems's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Apr. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 15.53% mean?
Veeva Systems (MEX:VEEV) has a Return-on-Tangible-Equity of 15.53% as of Apr. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Veeva Systems and its competitors. This is 19% below median its historical median of 19.28. Over the past decade, Veeva Systems' Return-on-Tangible-Equity has ranged from 14.33 to 27.25. According to the industry distribution chart, Veeva Systems ranks #229 out of 580 companies in the Healthcare Providers & Services industry, placing it in the top 39.5%.
Is Veeva Systems' Return-on-Tangible-Equity too high?
Veeva Systems' current Return-on-Tangible-Equity of 15.53% is 19% below median its 10-year median of 19.28. Over the past 10 years, this metric has ranged from a low of 14.33 to a high of 27.25. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.07. Veeva Systems' value of 15.53% is 54.3% above this industry median. Based on the distribution chart, Veeva Systems ranks #229 out of 580 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Veeva Systems has a GF Score™ of 93/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' Return-on-Tangible-Equity compare to BTSG and TEM?
According to the Healthcare Providers & Services industry distribution chart, Veeva Systems ranks #229 out of 580 companies for Return-on-Tangible-Equity. This puts Veeva Systems in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.07. Veeva Systems' value of 15.53% is 54.3% above this benchmark. Historically, Veeva Systems' own Return-on-Tangible-Equity has ranged from 14.33 to 27.25 over the past decade. While the company's 10-year median is 19.28 vs. the industry median of 10.07, Veeva Systems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.07, based on 580 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Veeva Systems's current Return-on-Tangible-Equity of 15.53% is 54.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Veeva Systems and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veeva Systems's current Return-on-Tangible-Equity is 15.53%, which is 19% below median its own 10-year median of 19.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (MEX:VEEV) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN5,077.50, compared to a current price of MXN3,333.33 — trading 34.4% below its estimated fair value. The current Return-on-Tangible-Equity is 15.53%, which is 19% below median its 10-year median of 19.28 and 54.3% above the Healthcare Providers & Services industry median of 10.07. Veeva Systems' overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Veeva Systems (MEX:VEEV), the current Return-on-Tangible-Equity is 15.53% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Veeva Systems (MEX:VEEV) Overvalued in 2026?
Based on GuruFocus' analysis, Veeva Systems stock appears to be undervalued.
The current stock price of MXN3,333.33 is trading 34.4% below its estimated GF Value™ of MXN5,077.50.
GuruFocus considers Veeva Systems to be Significantly Undervalued.
Key valuation signals for MEX:VEEV:
Return-on-Tangible-Equity: 15.53% (19% below median its 10-year median of 19.28)
GF Value™: MXN5,077.50 vs. price of MXN3,333.33 (34.4% below fair value)
Industry Position: 54.3% above the Healthcare Providers & Services median (#229 of 580)
No single metric tells the full story. See the MEX:VEEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
93GF Score
Get the complete analysis for MEX:VEEV
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:VEEV has been successfully added to your 
